Literature DB >> 2914620

Developmental regulation of five subunit specific mRNAs encoding acetylcholine receptor subtypes in rat muscle.

V Witzemann1, B Barg, M Criado, E Stein, B Sakmann.   

Abstract

The muscular content of the mRNAs encoding the five subunits of the nicotonic acetylcholine receptor was measured during postnatal development in the rat. Subunit specific mRNAs show differential regulation. The levels of the alpha-, gamma- and delta-subunit specific mRNAs decrease steadily after birth, while the beta- and epsilon-subunit mRNAs increase transiently and then decrease. The adult pattern of subunit specific mRNA levels is reached at 4-6 weeks postnatally. The content of gamma- and epsilon-subunit mRNA changes in a reciprocal fashion during the first 2 postnatal weeks, supporting the view that differential regulation of gamma- and epsilon-subunit mRNA during development is one mechanism mediating the appearance of the adult, epsilon-subunit containing, subtype of end-plate channel. Denervation of neonatal muscle increases the levels of all subunit-specific mRNAs during further development. It prevents the postnatal decrease in gamma-subunit mRNA and enhances the initial increase in epsilon-subunit mRNA. This makes it appear that the epsilon-subunit gene is less sensitive to regulation by the nerve in the postnatal period than the gamma-subunit gene.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2914620     DOI: 10.1016/0014-5793(89)80514-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  35 in total

1.  The 5'-flanking region of the mouse muscle nicotinic acetylcholine receptor beta subunit gene promotes expression in cultured muscle cells and is activated by MRF4, myogenin and myoD.

Authors:  C A Prody; J P Merlie
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

2.  A uniquely selective inhibitor of the mammalian fetal neuromuscular nicotinic acetylcholine receptor.

Authors:  Russell W Teichert; Jean Rivier; Josep Torres; John Dykert; Charleen Miller; Baldomero M Olivera
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

3.  Spontaneous and agonist-induced openings of an acetylcholine receptor channel composed of bovine muscle alpha-, beta- and delta-subunits.

Authors:  M B Jackson; K Imoto; M Mishina; T Konno; S Numa; B Sakmann
Journal:  Pflugers Arch       Date:  1990-10       Impact factor: 3.657

4.  Differential expression of three glutamate receptor genes in developing rat brain: an in situ hybridization study.

Authors:  D E Pellegrini-Giampietro; M V Bennett; R S Zukin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

5.  A novel role for embigin to promote sprouting of motor nerve terminals at the neuromuscular junction.

Authors:  Enzo Lain; Soizic Carnejac; Pascal Escher; Marieangela C Wilson; Terje Lømo; Nadesan Gajendran; Hans Rudolf Brenner
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

6.  A novel synapse-associated noncoding RNA.

Authors:  M A Velleca; M C Wallace; J P Merlie
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

7.  Acetylcholine receptor epsilon-subunit deletion causes muscle weakness and atrophy in juvenile and adult mice.

Authors:  V Witzemann; H Schwarz; M Koenen; C Berberich; A Villarroel; A Wernig; H R Brenner; B Sakmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

8.  Expression of the GABAA receptor delta subunit is selectively modulated by depolarization in cultured rat cerebellar granule neurons.

Authors:  L M Gault; R E Siegel
Journal:  J Neurosci       Date:  1997-04-01       Impact factor: 6.167

9.  Control of acetylcholine receptors in skeletal muscle.

Authors:  V Witzemann
Journal:  J Protein Chem       Date:  1989-06

10.  Neural regulation of acetylcholine receptors in rat neonatal muscle.

Authors:  L L Bambrick; T Gordon
Journal:  J Physiol       Date:  1992-04       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.